BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
glucose metabolic process
,
Diabetes mellitus
,
Kidney
,
Avian flu virus
,
Aspirin
,
IGF1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
STAs
Summary
General Info
Curated Studies
Most Correlated Studies
Ewing's sarcoma STA-ET-7 cells harboring TP53 mutations treated with APR-246
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
EWS-FLI1 knockdown in Ewing's sarcoma cell lines
Explore Curated Studies Results
Literature
Most Relevant Literature
Nuclear RPSA senses viral nucleic acids to promote the innate inflammatory response.
Characterization of disulfide bridges pattern of recombinant human interleukin 12 fusion protein p40…
Regression of Triple-Negative Breast Cancer in a Patient-Derived Xenograft Mouse Model by Monoclonal…
Variations of P40 and P63 Immunostains in Different Grades of Esophageal Squamous Cell Carcinoma: A …
Tryptophan (W) at position 37 of murine IL-12/IL-23 p40 is mandatory for binding to IL-12Rβ1 and sub…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase IIb Study of STA-2 in Patients With Chronic Stable Angina
Clinical and Translational Study of STA-9090
Open-label Study of STA-9090 for Patients With Metastatic Breast Cancer
Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Prev…
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ